HOUSTON: Researchers from Brown and Rhode Island hospitals hope that trans-cranial magnetic stimulation will become the first successful treatment for frontotemporal dementia.
FTD is a neurodegenerative disease and is “the second most common cause of dementia in younger people — individuals under 65 — following Alzheimer’s,” said Brian Ott, a professor at the Warren Alpert Medical School and the director of Rhode Island Hospital’s Alzheimer’s Disease and Memory Disorders Center.